Medpace Holdings earnings were $491.5M for the trailing 12 months ending Jun 30, 2026, with 25.7% growth year over year. The latest MEDP earnings report on Jun 30, 2026 announced Q2 2026 earnings of $121.4M, down 2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MEDP reported annual earnings of $451.1M, with 11.6% growth.
MEDP past earnings growth
How has MEDP's earnings growth performed historically?
What were Medpace Holdings's earnings last quarter?
On MEDP's earnings call on Jul 22, 2026, Medpace Holdings (NASDAQ: MEDP) reported Q2 2026 earnings per share (EPS) of $4.31, up 36.39% year over year. Total MEDP earnings for the quarter were $121.36 million. In the same quarter last year, Medpace Holdings's earnings per share (EPS) was $3.16.
As of the last Medpace Holdings earnings report, Medpace Holdings is currently profitable. Medpace Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $491.50 million, a 17.5% increase year over year.
What was MEDP's earnings growth in the past year?
As of Medpace Holdings's earnings date in Jul 22, 2026, Medpace Holdings's earnings has grown 25.69% year over year. This is 11.49 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 14.19%. MEDP earnings in the past year totalled $491.50 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.